These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9305368)

  • 1. Absence of anti-P/Q calcium channel antibody in the sera of patients with anti-Yo antibody-positive paraneoplastic cerebellar degeneration.
    Tanaka K; Motomura M; Nakao Y; Tanaka M; Tsuji S
    Neurology; 1997 Sep; 49(3):895-6. PubMed ID: 9305368
    [No Abstract]   [Full Text] [Related]  

  • 2. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
    Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
    Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
    Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
    N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
    Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
    Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma.
    Maddison P; Newsom-Davis J; Mills KR; Souhami RL
    Lancet; 1999 Jan; 353(9147):117-8. PubMed ID: 10023900
    [No Abstract]   [Full Text] [Related]  

  • 6. Autoantibody screening in subacute cerebellar ataxia.
    Trivedi R; Mundanthanam G; Amyes E; Lang B; Vincent A
    Lancet; 2000 Aug; 356(9229):565-6. PubMed ID: 10950237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Paraneoplastic neurologic syndromes. 2. Lambert-Eaton myasthenic syndrome. 2) Anti-calcium channel antibody and clinical features].
    Nakao Y; Motomura M; Suenaga A; Nakamura T; Yoshimura T; Tsujihata M; Ito M; Kono S; Eguchi K
    Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):685-90. PubMed ID: 9627478
    [No Abstract]   [Full Text] [Related]  

  • 8. P/Q-type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system.
    Voltz R; Carpentier AF; Rosenfeld MR; Posner JB; Dalmau J
    Muscle Nerve; 1999 Jan; 22(1):119-22. PubMed ID: 9883867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channel autoantibody and non-small-cell lung cancer in patients with Lambert-Eaton syndrome.
    Sher E; Comola M; Nemni R; Canal N; Clementi F
    Lancet; 1990 Feb; 335(8686):413. PubMed ID: 1968140
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndrome.
    Takamori M; Takahashi M; Yasukawa Y; Iwasa K; Nemoto Y; Suenaga A; Nagataki S; Nakamura T
    J Neurol Sci; 1995 Nov; 133(1-2):95-101. PubMed ID: 8583238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Report of a case of small cell lung cancer associated with Lambert-Eaton myasthenic syndrome and subacute cerebellar degeneration--with a review of the Japanese literature].
    Ohkubo K; Ohishi K; Motomura M; Sakai K; Tsujihata M; Nagataki S
    No To Shinkei; 1994 Mar; 46(3):285-9. PubMed ID: 8192944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do calcium channel autoantibodies cause cerebellar ataxia with Lambert-Eaton syndrome?
    Fletcher CF; Lennon VA
    Ann Neurol; 2003 Jan; 53(1):5-7. PubMed ID: 12509841
    [No Abstract]   [Full Text] [Related]  

  • 13. SOX1 autoantibodies: tumor markers in LEMS patients?
    Lang B; Evoli A
    Neurology; 2008 Mar; 70(12):906-7. PubMed ID: 18347313
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of antineural autoantibodies in a patient with paraneoplastic cerebellar syndrome and small cell lung carcinoma.
    Honnorat J; Aguera M; Guillon B; De Ferron E; Antoine JC; Dalmau J
    J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):425-6. PubMed ID: 9120474
    [No Abstract]   [Full Text] [Related]  

  • 15. Calcium channel autoantibodies in myasthenic syndrome and small cell lung cancer.
    Pelucchi A; Ciceri E; Clementi F; Marazzini L; Foresi A; Sher E
    Am Rev Respir Dis; 1993 May; 147(5):1229-32. PubMed ID: 8387255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of autoantibodies in Lambert-Eaton myasthenic syndrome.
    Lang B; Waterman S; Pinto A; Jones D; Moss F; Boot J; Brust P; Williams M; Stauderman K; Harpold M; Motomura M; Moll JW; Vincent A; Newsom-Davis J
    Ann N Y Acad Sci; 1998 May; 841():596-605. PubMed ID: 9668304
    [No Abstract]   [Full Text] [Related]  

  • 17. Humoral immunity against glutamic acid decarboxylase and tyrosine phosphatase IA-2 in Lambert-Eaton myasthenic syndrome.
    Hermitte L; Martin-Moutot N; Boucraut J; Barone R; Atlan-Gepner C; Seagar M; Pouget J; Kleisbauer JP; Couraud F; Vialettes B
    J Clin Immunol; 2000 Jul; 20(4):287-93. PubMed ID: 10939716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss.
    Tanaka M; Tanaka K; Onodera O; Tsuji S
    Clin Neurol Neurosurg; 1995 Feb; 97(1):95-100. PubMed ID: 7788981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lambert-Eaton myasthenic syndrome. Antigenicity of recombinant human P/Q-type calcium channel alpha 1 subunit putative ion pore region (domain IV, S5-S6).
    Black JL; Griesmann GE; Erickson J; Kryzer TJ; Lamke GT; Lennon VA
    Ann N Y Acad Sci; 1998 May; 841():691-5. PubMed ID: 9668316
    [No Abstract]   [Full Text] [Related]  

  • 20. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
    Tanaka K; Tanaka M; Onodera O; Tsuji S
    Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.